NCT06480019

Brief Summary

Major depressive disorder is a highly prevalent, recurrent, and debilitating disease, the third cause of years of lost life in the world, and it may be the most common disease in 2030, according to the World Health Organization (WHO). Furthermore, it's also related to decreased quality of life and high mortality. Interpersonal psychotherapy (IPT) is a first-line treatment and can also be used for the prevention of depression. This randomized controlled clinical trial is planned to have 50 participants randomized between an interventional and a control group (waiting list). Our study covers young adults (18 to 24 years old) with depression. Participants will be invited by social media to undergo treatment in an IPT group. The intervention group will be separated into groups with up to 10 participants, with a weekly meeting for eight weeks. The intervention will focus on interpersonal relationships within the model of IPT and will be held by a university student and a doctor trained in IPT.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
32mo left

Started Mar 2024

Longer than P75 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Mar 2024Dec 2028

Study Start

First participant enrolled

March 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 28, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

April 13, 2026

Status Verified

October 1, 2025

Enrollment Period

2.8 years

First QC Date

June 24, 2024

Last Update Submit

April 8, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hospital Anxiety and Depression Scale (HADS)

    The Hospital Anxiety and Depression Scale consists of 14 items, of which 7 assess anxiety and 7 assess depression. Each item is scored from 0 to 3, and each subscale has a maximum score of 21 points with higher scores indicating greater symptom severity.

    Pre-treatment, Week 1 to 8

Secondary Outcomes (5)

  • Patient Health Questionnaire-9

    Pre-treatment, Week 1 to 8

  • Social support scale (MOS-SSS)

    Pre-treatment, Week 1 to 8

  • Quality of Life (WHOQOL-BREF)

    Pre-treatment, Week 1 to 8

  • Clinical Global Impression (CGI)

    Pre-treatment, Week 1 to 8

  • Beck Depression Inventory (BDI)

    Pre-treatment; Week 1-8

Other Outcomes (6)

  • Resilience (CD-RISC-10)

    Pre-treatment, Week 1 to 8

  • Psychotherapy side effects (UE-ATR checklist)

    Week 1 to 8

  • Childhood Trauma Questionnaire (CTQ)

    Week 1

  • +3 more other outcomes

Study Arms (2)

Intervention

OTHER

Participants that receive psychotherapy

Behavioral: Interpersonal psychotherapy

Waiting list

NO INTERVENTION

Participants that are waiting for intervention

Interventions

Interpersonal psychotherapy is a first-line treatment and can also be used for the prevention of depression.

Intervention

Eligibility Criteria

Age18 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Young adults (between 18 and 24 years old)
  • Young adults who work, live or study in Porto Alegre
  • PHQ ≥ 5 - without suicide ideation

You may not qualify if:

  • Maniac or hypomanic episode
  • Psychotic Syndrome
  • Substance Abuse
  • Suicide Risk or Ideation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Hospital for Porto Alegre

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

RECRUITING

MeSH Terms

Conditions

Depression

Interventions

Interpersonal Psychotherapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Neusa Sica da Rocha, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 24, 2024

First Posted

June 28, 2024

Study Start

March 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2028

Last Updated

April 13, 2026

Record last verified: 2025-10

Locations